Illumina, Inc

Introduction
Illumina is a global leader in genomics and DNA sequencing technologies. Founded in 1998, the company develops and markets integrated systems for the analysis of genetic variation and function. Illumina’s sequencing platforms are widely used in biomedical research, clinical diagnostics, oncology, reproductive health, agriculture, and population genomics projects. The company has played a pivotal role in making whole-genome sequencing more accessible and cost-effective.

Mission and Vision

Mission: To improve human health by unlocking the power of the genome.
Vision: A future where genomics is an integral part of healthcare, enabling precision medicine and better outcomes for all.

Products and Services

Sequencing Platforms: NovaSeq, NextSeq, MiSeq, iSeq, and other next-generation sequencing (NGS) systems.
Consumables & Reagents: Kits and tools supporting genomics workflows.
Software & Data Analysis: Bioinformatics solutions for genomic research and clinical applications.
Clinical & Applied Genomics: Non-invasive prenatal testing, oncology diagnostics, and population genomics initiatives.
Partnerships: Collaboration with healthcare providers, governments, and biotech firms to expand genomic medicine.

Growth and Innovation
Illumina has been instrumental in reducing the cost of whole-genome sequencing from billions of dollars to under $1,000, accelerating the rise of precision medicine. The company continues to expand into clinical applications, particularly in oncology (liquid biopsy, cancer screening), rare diseases, and reproductive health. Despite regulatory challenges with its acquisition attempts (e.g., Grail), Illumina remains a cornerstone of the genomics industry.

Global Impact
Illumina’s technology is used by research institutions, governments, and biotech companies worldwide, driving advances in personalized medicine, pandemic response, and genetic disease research. Its sequencing platforms power national genome projects in multiple countries and help accelerate innovation in cancer detection, infectious disease monitoring, and agricultural genomics.